Showing results (1231-1240 of 1,248) with videos related to
Sort By:
Pageof 125
Nature Communications|September 25, 2020
Fabrication of a novel magnetic topological heterostructure and temperature evolution of its massive Dirac coneT Hirahara, M M Otrokov, T T Sasaki, et al.The Japanese Journal of Antibiotics|February 1, 1983
[The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics]T Miwatani, Y Takeda, K Kotera, et al.Molecular Cell|August 7, 2018
Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate OncogenesisGabriel J Sandoval, John L Pulice, Hubert Pakula, et al.Cell|June 19, 2018
A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate CancerDavid Y Takeda, Sándor Spisák, Ji-Heui Seo, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1996
[Phase II study of paclitaxel (BMS-181339) in patients with ovarian cancer by 3-hour intravenous infusion]K Noda, M Ikeda, R Kudo, et al.Scientific Reports|August 9, 2020
Nature of the Dirac gap modulation and surface magnetic interaction in axion antiferromagnetic topological insulatorA M Shikin, D A Estyunin, I I Klimovskikh, et al.Nature Genetics|September 7, 2022
Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulationSylvan C Baca, Cassandra Singler, Soumya Zacharia, et al.Cancer Research|December 9, 2024
Plasma Cell-Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate CancerJoonatan Sipola, Aslı D Munzur, Edmond M Kwan, et al.The Prostate|January 27, 2022
Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samplesElizabeth H Stover, Coyin Oh, Paula Keskula, et al.Cell Reports|February 23, 2022
A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancerStephen Tang, Vidyalakshmi Sethunath, Nebiyou Y Metaferia, et al.Pageof 125